How to manage a patient with a urinary tract infection (UTI) who is clinically improving on nitrofurantoin but has a culture indicating the presence of Proteus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of UTI with Proteus Species While on Nitrofurantoin

For a patient with a urinary tract infection who is clinically improving on nitrofurantoin but has a urine culture showing Proteus species, the antibiotic should be changed to a more appropriate agent such as trimethoprim-sulfamethoxazole or ciprofloxacin, as Proteus species are intrinsically resistant to nitrofurantoin. 1, 2

Why Nitrofurantoin Is Ineffective Against Proteus

  • Proteus species are intrinsically resistant to nitrofurantoin, making it an inappropriate choice regardless of clinical improvement 1
  • Proteus produces urease, which alkalinizes the urine (pH ≥8), further reducing nitrofurantoin's effectiveness 2, 3
  • Studies show that at urine pH 8-9, only 66.1% of urinary isolates remain sensitive to nitrofurantoin, dropping to 54.6% at pH 9 2
  • Alkaline urine in the emergency department is a predictor of nitrofurantoin resistance 2

Recommended Alternative Treatment Options

First-line options:

  • Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3 days (uncomplicated cystitis) or 14 days (pyelonephritis) 4, 5
  • Ciprofloxacin: 500 mg twice daily for 7 days 4, 6

Alternative options:

  • Cephalosporins (e.g., cefpodoxime 200 mg twice daily for 10 days) 4
  • Aminoglycosides (e.g., gentamicin) for more severe infections 4, 7

Clinical Decision Algorithm

  1. Confirm Proteus infection: Verify that Proteus is the causative organism from culture results 4
  2. Assess clinical status:
    • If improving but still symptomatic: Change to appropriate antibiotic immediately 4, 1
    • If completely asymptomatic: Still change antibiotic to prevent relapse, as clinical improvement may be temporary despite inappropriate therapy 1
  3. Check for complications:
    • Assess for urinary pH (alkaline urine suggests Proteus) 2
    • Consider imaging if there are risk factors for stone formation, as Proteus can promote struvite stones 4, 3
  4. Select appropriate antibiotic based on susceptibility testing 4
  5. Complete appropriate duration of therapy based on infection severity 4

Important Considerations

  • Proteus species (including P. mirabilis and P. vulgaris) account for approximately 18% of UTIs, with higher prevalence in catheterized patients 7
  • Proteus UTIs are associated with a higher risk of stone formation due to urease production and urine alkalinization 3
  • Gentamicin and nalidixic acid show >92% sensitivity against Proteus isolates in some studies 7
  • Fluoroquinolones and cephalosporins are the only antimicrobials recommended for oral empiric treatment of upper UTIs, while nitrofurantoin should be avoided due to insufficient efficacy data 4

Pitfalls to Avoid

  • Don't continue nitrofurantoin despite clinical improvement: Clinical improvement may be temporary or incomplete, and continuing an ineffective antibiotic can lead to treatment failure or recurrence 1, 2
  • Don't ignore alkaline urine: pH ≥8 strongly suggests Proteus infection and predicts nitrofurantoin resistance 2
  • Don't overlook the risk of stone formation: Proteus infections can lead to struvite stones due to urease activity 3
  • Don't forget to assess for complicated UTI: Proteus infections are more common in patients with structural abnormalities or indwelling catheters 4, 7

By promptly changing to an appropriate antibiotic based on culture results, you can ensure complete eradication of the infection and prevent complications associated with Proteus UTIs.

References

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Research

Proteus vulgaris urinary tract infections in rats; treatment with nitrofuran derivatives.

British journal of pharmacology and chemotherapy, 1962

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevalence of Proteus species in urinary tract infections in a regional hospital in Trinidad.

Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.